ST-gliptin Dapa Tablet is primarily used to manage type 2 diabetes in adults. This combination medicine belongs to a group of medications known as SGLT2 inhibitors and DPP-4 inhibitors.
Besides managing type 2 diabetes, this medicine is also employed to reduce the risk of hospitalisation for heart failure in adults who have type 2 diabetes with established cardiovascular disease or multiple cardiovascular risk factors. Additionally, it can help decrease the risk of kidney function decline, end-stage kidney disease, cardiovascular death and hospitalisation for heart failure in adults with chronic kidney disease.
Before you start taking this medicine, it is crucial to consult your doctor about the correct dosage and frequency. You should inform your doctor about any pre-existing conditions or current medications before beginning the treatment. If you notice any side effects while on this medication, notify your doctor immediately. For optimal results, continue taking the tablet for the duration prescribed by your doctor.